CURV
Torrid Holdings Inc.
CURV offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over CURV overall, supported by stronger valuation and lower modeled downside.
CURV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
CURV's revenue, profitability, cash flow and balance sheet are all currently under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CURV PE Valuation
CURV has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 40x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CURV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
CURV has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CURV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.06 | — |
| Q3 2026 | -$0.10 | -433% |
| Q2 2026 | -$0.13 | -244% |
| Q1 2026 | -$0.07 | -147% |
| Q4 2025 | -$0.02 | -113% |
| Q3 2025 | $0.03 | -79% |
| Q2 2025 | $0.09 | -25% |
| Q1 2025 | $0.15 | +36% |
| Q4 2024 | $0.16 | +60% |
CURV has swung to a loss: it lost $0.10 per share over the past year, after a profit the year before.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over CURV on earnings quality, reporting a profit while its opponent remains loss making.
CURV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $231.7M | -12% |
| Q2 2026 | $245.8M | -7.6% |
| Q1 2026 | $236.2M | -14% |
| Q4 2025 | $235.2M | -11% |
| Q3 2025 | $262.8M | -7.7% |
| Q2 2025 | $266M | -4.9% |
| Q1 2025 | $275.6M | -6.1% |
| Q4 2024 | $263.8M | -4.2% |
CURV's revenue has slid since its 2022 peak: $232M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +2.4 points |
| Q2 2026 | 3.5% | -2.6 points |
| Q1 2026 | -2.1% | -3.4 points |
| Q4 2025 | 0.1% | -2.6 points |
| Q3 2025 | 3.9% | -3.3 points |
| Q2 2025 | 6% | -3.3 points |
| Q1 2025 | 1.3% | -0.1 points |
| Q4 2024 | 2.7% | +0.2 points |
CURV's operating margin was 6.3% last quarter, up 2.4 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over CURV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over CURV on profitability, with a higher operating margin.
CURV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -121% |
| Q2 2026 | $5.7M | +$26.3M |
| Q1 2026 | -$9.3M | -191% |
| Q4 2025 | -$6.6M | -$1.1M |
| Q3 2025 | $14.6M | -61% |
| Q2 2025 | -$20.6M | -200% |
| Q1 2025 | $10.2M | +$12M |
| Q4 2024 | -$5.5M | -$1.9M |
CURV's free cash flow was −$13M over the past year, against −$1M the year before.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over CURV on cash generation, producing positive trailing cash flow while its opponent burns cash.
CURV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +667K shares |
| 1 year | -2.5% | -2.5M shares |
| 3 years | -3.8% | -4M shares |
| 5 years | -8.9% | -9.8M shares |
| Available history | -8.9% | -9.8M shares |
CURV has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $186,000 |
| Q1 2026 | — |
| Q4 2025 | $85,000 |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CURV spent $271,000 buying back its own shares over the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CURV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 5.2x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.6x | Moderate |
CURV's net debt is about 5.2 years of its operating earnings (EBITDA), up from 3.5 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over CURV on leverage, with a lower net debt burden relative to earnings.
CURV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 35.0 | Neutral |
CURV's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CURV PE vs Consumer Cyclical Sector
| Metric | CURV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CURV has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CURV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.33 | 4.3% below |
| 20 week MA | $2.30 | 3% below |
| 50 week MA | $1.78 | 25% above |
| 100 week MA | $2.88 | 23% below |
| 200 week MA | $3.56 | 37% below |
CURV's trend is mixed: it's above one of its five weekly moving averages, and 37% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CURV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.6 | $10.1 | -62% |
| 2022 | $10.1 | $3.02 | -70% |
| 2023 | $3.02 | $5.77 | +91% |
| 2024 | $5.77 | $5.28 | -8.5% |
| 2025 | $5.28 | $1.04 | -80% |
| 2026 YTD | $1.04 | $2.23 | +114% |
CURV has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.